Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.75
+0.49 (9.32%)
At close: Dec 20, 2024, 4:00 PM
5.90
+0.15 (2.61%)
After-hours: Dec 20, 2024, 7:59 PM EST
Personalis Market Cap
Personalis has a market cap or net worth of $406.23 million as of December 20, 2024. Its market cap has increased by 459.80% in one year.
Market Cap
406.23M
Enterprise Value
307.73M
1-Year Change
459.80%
Ranking
Category
Stock Price
$5.75
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $406.23M, a decrease of -52.07%. That is a compound annual growth rate of -12.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 406.23M | 294.53% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.66% |
| Dec 31, 2019 | 340.45M | -59.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 384.49M |
| Y-mAbs Therapeutics | 383.84M |
| Quanterix | 383.41M |
| Taysha Gene Therapies | 379.15M |
| ZimVie | 373.14M |
| REGENXBIO | 367.13M |
| Delcath Systems | 357.47M |
| Sana Biotechnology | 357.23M |